JPH1175770A - Peroxylipid production inhibitor, its production and utulization thereof - Google Patents

Peroxylipid production inhibitor, its production and utulization thereof

Info

Publication number
JPH1175770A
JPH1175770A JP9285949A JP28594997A JPH1175770A JP H1175770 A JPH1175770 A JP H1175770A JP 9285949 A JP9285949 A JP 9285949A JP 28594997 A JP28594997 A JP 28594997A JP H1175770 A JPH1175770 A JP H1175770A
Authority
JP
Japan
Prior art keywords
extract
production
lipid peroxide
inhibitor
essence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9285949A
Other languages
Japanese (ja)
Inventor
Takeo Ishihara
健夫 石原
Takafumi Ishihara
隆文 石原
Hiromichi Okuda
拓道 奥田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIZEN KASEI KK
Original Assignee
BIZEN KASEI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIZEN KASEI KK filed Critical BIZEN KASEI KK
Priority to JP9285949A priority Critical patent/JPH1175770A/en
Publication of JPH1175770A publication Critical patent/JPH1175770A/en
Pending legal-status Critical Current

Links

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

PROBLEM TO BE SOLVED: To produce the subject safe agent capable of inhibiting the production of peroxylipids in vivo and in vitro and manifesting strong antioxidizing activities by including an essence extracted from a leaf of Psidium guajava L. as an active ingredient therein. SOLUTION: This agent is a peroxylipid production inhibitor containing an essence prepared by extracting a leaf of Psidium guajava L. with water or a hydrophilic organic solvent (preferably a lower monohydric alcohol, especially preferably ethanol) or a mixed solvent thereof as an active ingredient. The leaf of the Psidium guajava L. used is preferably a dried material or a pulverized material and fragmented to, e.g. about 1 mm to several cm, average 5 cm square size. The extraction of the essence is preferably carried out under an applied pressure of 1.2-5 atom and under heating. The agent manifests synergistic effects thereof by using the essence extracted from the leaf of the Psidium guajava L. with an essence extracted from grape seeds and/or an essence extracted from a bark of Pinus pinaster in combination.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、グアバ(学名:P
sidium Guajava Limn)の葉から得
られる抽出エキスを有効成分としてなる過酸化脂質抑制
剤およびその製造法に関するものであり、また該抑制剤
を配合してなる食品、化粧品、農薬、医薬品等の組成物
とりわけ食品に関するものである。
TECHNICAL FIELD The present invention relates to guava (scientific name: P
The present invention relates to a lipid peroxide inhibitor comprising an extract obtained from the leaves of C. siumium Guajava Limn) as an active ingredient and a method for producing the same, and a composition of the food, cosmetics, agrochemicals, pharmaceuticals, etc. comprising the inhibitor. It is especially about food.

【0002】[0002]

【従来の技術】近年、欧米型食生活が定着化するにとも
ない脂肪の摂取量が増え、日本人の平均的摂取エネルギ
ーのうち脂肪に由来するものはすでに欧米なみのレベル
に達しており、ここ数年来、脂肪の過剰摂取による高脂
血症、動脈硬化症、虚血性心疾患、脳梗塞等の各種疾病
の誘発のリスクが警告されている。また、脂質の構成脂
肪酸として飽和脂肪酸を多く含むものは血中コレステロ
ール値の上昇をまねくため、不飽和脂肪酸の積極的な摂
取が提言され、飽和脂肪酸と1価不飽和脂肪酸と多価不
飽和脂肪酸とのバランスが重要であるともいわれてい
る。
2. Description of the Related Art In recent years, as the Western diet has become established, the amount of fat intake has increased, and among the average energy intake of Japanese, those derived from fat have already reached levels comparable to those in the West. For several years, the risk of inducing various diseases such as hyperlipidemia, arteriosclerosis, ischemic heart disease, and cerebral infarction due to excessive intake of fat has been warned. In addition, those containing a large amount of saturated fatty acids as constituent fatty acids of lipids may cause an increase in blood cholesterol level. Therefore, active intake of unsaturated fatty acids is recommended, and saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids are recommended. It is also said that the balance with is important.

【0003】不飽和脂肪酸の構成比が高い脂質は、これ
を摂取するかしないかにかかわらず過酸化物を生じやす
く、酸化劣化しやすい。いわゆる不飽和脂質を製品に配
合することが多い食品、化粧品、農薬、医薬品等の分野
では、一般的に、トコフェロール、アスコルビン酸エス
テル等の抗酸化剤を併用することにより、不飽和脂質の
酸化劣化を防止することが行われているが、実際の酸化
防止効果には限度があり、各種製品の酸敗臭や変色を招
くことが多い。また、生体内で生じる過酸化脂質や酸化
した食品を摂取することが肝臓障害、動脈硬化、血栓症
等をひきおこす原因のひとつになり、さらには種々の老
化現象に密接に関係することも指摘されている。例え
ば、ラットに不飽和脂肪酸を長期間投与したり、過酸化
脂質を投与すると肝臓障害が発生することが知られてい
る。このように、不飽和脂質の製品への利用や摂取の機
会が増えるにつれて酸化防止、過酸化脂質の生成を抑制
する必要性が高まっている。
[0003] Lipids having a high proportion of unsaturated fatty acids are liable to generate peroxides and oxidatively deteriorate regardless of whether they are ingested or not. In the fields of foods, cosmetics, agricultural chemicals, pharmaceuticals, etc., where so-called unsaturated lipids are often added to products, the oxidative deterioration of unsaturated lipids is generally achieved by using antioxidants such as tocopherol and ascorbate together. However, the actual antioxidant effect is limited and often leads to rancidity and discoloration of various products. It has also been pointed out that ingestion of lipid peroxides and oxidized foods produced in the body is one of the causes of liver damage, arteriosclerosis, thrombosis, etc., and is also closely related to various aging phenomena. ing. For example, it is known that liver damage occurs when rats are administered unsaturated fatty acids for a long time or lipid peroxide. Thus, as the use of unsaturated lipids in products and opportunities for ingestion increase, the need to prevent oxidation and suppress the production of lipid peroxides has increased.

【0004】一般に、天然物として利用する植物体に
は、サポニン、フラボノイド、タンニン等の成分が含ま
れ、フラボノイドやタンニンは抗酸化作用を有すること
が知られている。例えば、ブドウ種子を適宜に破砕し、
親水性有機溶媒あるいはこの含水溶媒で抽出して得られ
るエキスにはポリフェノール類が多く含まれ、とりわけ
フラボノイドの1種であるアントシアニジン、プロアン
トシアニジン等が多く、該エキスには抗酸化機能がある
ため、ブドウ種子抽出エキスの抗酸化剤として市販され
ている。また、フランスのボルドー地方に生育する松の
一種(フランス海岸松、Pinus pinaste
r)の樹皮を同様に水またはエタノール等の親水性有機
溶媒の含水物で抽出して得られるエキスはプロアントシ
アニジンおよび40種類以上の有機酸(カテキン−カテ
キン−プロシアニジン類、エピカテキン−カテキン−プ
ロシアニジン類、カテキン、カフェイン酸、フェルリッ
ク酸等)を含み、抗酸化活性や活性酸素消去作用を有し
ており、「ピクノジェノール」という商品名で市販され
ている(松下祐治、Fragrannce Journ
al、1997年4月号、第70頁〜第74頁)。
[0004] In general, plants used as natural products contain components such as saponins, flavonoids and tannins, and flavonoids and tannins are known to have an antioxidant effect. For example, crush the grape seeds appropriately,
Extracts obtained by extraction with a hydrophilic organic solvent or a water-containing solvent contain a large amount of polyphenols, particularly anthocyanidins, which are a kind of flavonoids, proanthocyanidins, etc., because the extract has an antioxidant function, It is commercially available as an antioxidant for grape seed extract. In addition, a kind of pine growing in the Bordeaux region of France (French coastal pine, Pinus pinaste)
The extract obtained by similarly extracting the bark of r) with water or a hydrate of a hydrophilic organic solvent such as ethanol contains proanthocyanidins and 40 or more organic acids (catechin-catechin-procyanidins, epicatechin-catechin-procyanidins). , Catechin, caffeic acid, ferric acid, etc.), has an antioxidant activity and an active oxygen scavenging effect, and is marketed under the trade name of "Pycnogenol" (Yuji Matsushita, Fragrance Journal)
al, April 1997, pp. 70-74).

【0005】前述のようにフラボノイドとくにプロアン
トシアニジンを含有する植物体の抽出エキス類は抗酸化
機能をもつが、実際の使用に当たっては該機能が十分で
あるとはいえず、より強力で有効な抗酸化活性を有し、
過酸化脂質の生成を抑制するものが求められていた。
[0005] As described above, plant extracts containing flavonoids, especially proanthocyanidins, have an antioxidant function, but they cannot be said to have sufficient functions in actual use. Has oxidizing activity,
What suppresses the production of lipid peroxide has been demanded.

【0006】[0006]

【発明が解決しようとする課題】かかる現状に鑑み、本
発明では、生体内外における過酸化脂質の生成を抑制
し、強力な抗酸化活性を有する、安全な過酸化脂質生成
抑制剤(以下、過酸化脂質抑制剤という)およびその製
造法を開発し、また過酸化脂質の生成が抑制され、酸化
安定性に優れた食品、化粧品、農薬、医薬品等の組成物
を提供することを目的とした。
SUMMARY OF THE INVENTION In view of the above situation, the present invention provides a safe lipid peroxide production inhibitor (hereinafter referred to as a peroxide inhibitor) which suppresses the production of lipid peroxide in and outside a living body and has a strong antioxidant activity. (Hereinafter referred to as a lipid oxidant inhibitor) and a process for producing the same, and to provide compositions of foods, cosmetics, agricultural chemicals, pharmaceuticals, and the like, in which the production of lipid peroxide is suppressed and excellent in oxidative stability.

【0007】[0007]

【課題を解決するための手段】前記課題の過酸化脂質抑
制剤は、グアバの葉を、水もしくは親水性有機溶媒また
はこれらの混合溶媒で抽出して得られるエキスを有効成
分として含有してなる過酸化脂質抑制剤によって達成さ
れる。ここで、抽出は1.2〜5気圧の加圧下かつ加熱
下で行うことが好ましく、さらには1.2〜1.7気圧
の加圧下かつ100〜130℃の加熱下で行うことがよ
り好ましい。なお、本発明の過酸化脂質抑制剤は、前記
グアバ葉からの抽出エキスを有効成分としてなるもので
あるが、植物体からの抽出エキスであって、プロアント
シアニジンを含む前記抽出エキス、より好ましくはブド
ウ種子からの抽出エキスおよび/またはフランス海岸松
(Pinus pinaster)の樹皮からの抽出エ
キス、をさらに含有してなるものが望ましい。
Means for Solving the Problems The lipid peroxide inhibitor of the above-mentioned problem comprises, as an active ingredient, an extract obtained by extracting guava leaves with water, a hydrophilic organic solvent or a mixed solvent thereof. Achieved by lipid peroxide inhibitors. Here, the extraction is preferably performed under a pressure of 1.2 to 5 atm and under heating, and more preferably under a pressure of 1.2 to 1.7 atm and under heating at 100 to 130 ° C. . In addition, the lipid peroxide inhibitor of the present invention comprises an extract from the guava leaf as an active ingredient, but is an extract from a plant, and the extract containing proanthocyanidin, more preferably It is preferable that the extract further contains an extract from grape seeds and / or an extract from bark of French pine (Pinus pinaster).

【0008】前記課題の製造法は、グアバの葉を、水も
しくは親水性有機溶媒またはこれらの混合溶媒を用い、
1.2〜5気圧、より好ましくは1.2〜1.7気圧の
加圧下、かつ加熱下、より好ましくは100〜130℃
の加熱下で抽出して得られるエキスを有効成分として含
有せしめることで達成される。また、前記課題の組成物
は、前記過酸化脂質抑制剤を配合してなる食品、化粧
品、農薬、医薬品等の組成物とくに食品組成物となすこ
とによって達成される。
[0008] In the production method of the above-mentioned subject, guava leaves are treated with water or a hydrophilic organic solvent or a mixed solvent thereof,
1.2-5 atm, more preferably 1.2-1.7 atm under pressure and under heating, more preferably 100-130 ° C
It is achieved by incorporating an extract obtained by extraction under heating as an active ingredient. Further, the composition of the object can be achieved by forming a composition such as food, cosmetics, agrochemicals, pharmaceuticals and the like, particularly a food composition, containing the lipid peroxide inhibitor.

【0009】[0009]

【発明の実施の形態】本発明の過酸化脂質抑制剤は、グ
アバの葉を、水もしくは親水性有機溶媒またはこれらの
混合溶媒を用いて抽出して得られるエキスを有効成分と
して含有してなるものである。
BEST MODE FOR CARRYING OUT THE INVENTION The lipid peroxide inhibitor of the present invention comprises, as an active ingredient, an extract obtained by extracting guava leaves with water or a hydrophilic organic solvent or a mixed solvent thereof. Things.

【0010】グアバは熱帯アメリカ原産の、フトモモ科
に属する植物で、熱帯各地、台湾、沖縄等で栽培され、
果汁はジュース飲料として利用されている。本発明では
グアバの葉部を抽出エキスの原料とする。該葉部は生の
ままでもよいが、抽出効率の点から乾燥物またはその破
砕物、例えば約1mm〜数cm、平均5mm角の大きさ
に細片化したものを使用することが好ましい。
Guava is a plant belonging to the family Myrtaceae native to tropical America and cultivated in various places in the tropics, Taiwan, Okinawa and the like.
Fruit juice is used as a juice beverage. In the present invention, guava leaves are used as a raw material for the extract. The leaves may be raw, but from the viewpoint of extraction efficiency, it is preferable to use a dried product or a crushed product thereof, for example, a product obtained by slicing into a size of about 1 mm to several cm and an average of 5 mm square.

【0011】親水性有機溶媒としては低級1価アルコー
ルが好適であり、メタノール、エタノール、n−プロパ
ノール、イソプロパノール、n−ブタノール、イソブタ
ノール等を例示できるが、本発明の所望の効果および食
品用途における安全性等を考慮すればエタノールが好ま
しい。かかる親水性有機溶媒は水との混合溶媒として使
用することがさらに望ましい。混合溶媒の種類および比
率は任意であるが、アルコール濃度が20〜90重量
%、より好ましくは40〜70重量%の含水アルコール
とするのがよい。この範囲を外れると抽出エキスの過酸
化脂質抑制効果が小さくなる。前記溶媒はグアバ葉に対
して1〜10重量倍程度用いればよい。
As the hydrophilic organic solvent, a lower monohydric alcohol is preferable, and examples thereof include methanol, ethanol, n-propanol, isopropanol, n-butanol and isobutanol. Ethanol is preferred in consideration of safety and the like. Such a hydrophilic organic solvent is more desirably used as a mixed solvent with water. The type and ratio of the mixed solvent are arbitrary, but it is preferable to use a hydrous alcohol having an alcohol concentration of 20 to 90% by weight, more preferably 40 to 70% by weight. Outside this range, the lipid peroxide-suppressing effect of the extracted extract is reduced. The solvent may be used about 1 to 10 times the weight of guava leaves.

【0012】本発明に係るエキスの抽出に際しては、
1.2〜5気圧の加圧下かつ加熱下で行うことが好まし
く、さらには1.2〜1.7気圧の加圧下かつ100〜
130℃の加熱下で行うことがより好ましい。この条件
のもとで抽出して得られるエキスは、過酸化脂質抑制効
果が顕著であり望ましい。グアバの葉および前記溶媒の
混合物を適宜に攪拌しながら、約10分間〜約5時間、
より好ましくは30分間〜2時間、前記条件下でグアバ
葉中の成分を抽出し、残渣を除去して抽出液を得、これ
を減圧濃縮、フリーズドライ、スプレードライ等の処理
に供して本発明のグアバ葉抽出エキス(液状または粉末
状)を製造することができる。なお、抽出液あるいは濃
縮液を活性炭で処理するとよい。
When extracting the extract according to the present invention,
It is preferably carried out under a pressure of 1.2 to 5 atm and under heating, more preferably under a pressure of 1.2 to 1.7 atm and 100 to
More preferably, it is performed under heating at 130 ° C. Extracts obtained by extraction under these conditions have a remarkable lipid peroxide suppressing effect, and are therefore desirable. While appropriately stirring the mixture of guava leaves and the solvent, from about 10 minutes to about 5 hours,
More preferably, the components in the guava leaf are extracted under the above conditions for 30 minutes to 2 hours, and the residue is removed to obtain an extract, which is subjected to processes such as concentration under reduced pressure, freeze drying, spray drying and the like, to thereby obtain the present invention. Guava leaf extract (liquid or powder) can be produced. The extract or the concentrate may be treated with activated carbon.

【0013】本発明に係るグアバ葉抽出エキスは、ポリ
フェノール系物質であるストリクチニン、イソストリク
チニン等のタンニンを主要な成分として含み、この他に
サポニン、エラグ酸配糖体、フラボノイド等を含む複雑
な組成である。該エキスは大豆油、菜種油、アマニ油、
ラード、魚油等の一般の不飽和脂質の過酸化物の生成を
抑制することはもちろん不飽和炭化水素等の酸化を抑制
し、動物の肝臓組織のミトコンドリア画分やミクロソー
ム画分における過酸化脂質の生成を抑制する作用に優
れ、また活性酸素の消去機能を有する。
The guava leaf extract according to the present invention contains tannins such as strictinin and isostrictinin, which are polyphenolic substances, as main components, and a complex composition containing saponins, ellagic acid glycosides, flavonoids and the like. It is. The extract is soybean oil, rapeseed oil, linseed oil,
In addition to suppressing the production of peroxides of general unsaturated lipids such as lard and fish oil, it also suppresses the oxidation of unsaturated hydrocarbons and the like, and reduces the production of lipid peroxide in the mitochondrial fraction and microsomal fraction of animal liver tissue. It has an excellent effect of suppressing generation and has a function of eliminating active oxygen.

【0014】本発明の過酸化脂質抑制剤は上記のような
グアバ葉抽出エキスを有効成分として含有してなるもの
であり、該抽出エキス単独でも構成されるが、さらに他
の抗酸化剤たとえばトコフェロール、アスコルビン酸パ
ルミテート等を適宜に含有せしめてもよい。本発明のグ
アバ葉からの抽出エキスと他の抗酸化剤とを併用する場
合、他の抗酸化剤としては特に植物体からの抽出エキス
であって、フラボノイドの1種であるプロアントシアニ
ジンを含有するものを選択すると相乗効果が発現するた
め望ましい。
The lipid peroxide inhibitor of the present invention contains the above extract of guava leaf as an active ingredient, and is composed of the extract alone, but further comprises another antioxidant such as tocopherol. , Ascorbic acid palmitate and the like may be appropriately contained. When the extract of guava leaves of the present invention is used in combination with another antioxidant, the other antioxidant is, in particular, an extract from a plant and contains proanthocyanidin, which is one of flavonoids. It is desirable to select one because a synergistic effect is exhibited.

【0015】プロアントシアニジンを含む植物抽出エキ
スとしては、ブドウ種子からの抽出エキスおよびフラン
ス海岸松(Pinus pinaster)の樹皮から
の抽出エキスを好適な例としてあげることができ、本発
明ではこれらのいずれか一方あるいは両方を使用でき
る。なお、プロアントシアニジンを含有する抽出エキス
はプロアントシアニジンを該エキス中に10重量%以
上、より好ましくは30重量%以上含有するものであ
る。また、本発明の過酸化脂質抑制剤において、グアバ
葉抽出エキスとプロアントシアニジン含有植物抽出エキ
スとの比率は任意であるが、前者:後者(重量比)=
1:0.1〜10が好ましく、1:0.5〜1がより好
ましい。
Preferred examples of plant extracts containing proanthocyanidins include extracts from grape seeds and extracts from the bark of French pine (Pinus pinaster). In the present invention, any of these extracts is used. Either or both can be used. The extract containing proanthocyanidin contains proanthocyanidin in an amount of 10% by weight or more, more preferably 30% by weight or more. In the lipid peroxide inhibitor of the present invention, the ratio of the guava leaf extract to the proanthocyanidin-containing plant extract is arbitrary, but the former: the latter (weight ratio) =
1: 0.1 to 10 is preferable, and 1: 0.5 to 1 is more preferable.

【0016】ブドウ種子からの抽出エキスは、前述のよ
うに、ブドウ種子をエタノール等の親水性有機溶媒また
はその含水溶媒で抽出して得られるエキスであり、市販
品として「アクティビン」(インターヘルス社製)、
「KPA−40」(キッコーマン(株)製)、「グレー
プ シード エキストラクト」(ファームライン社製)
等を例示できるが、本発明はこれらによって何ら制限さ
れるものではない。また、フランス海岸松の樹皮からの
抽出エキスも、前述のようにエタノール等の親水性有機
溶媒またはこの含水溶媒で抽出して得られるエキスであ
り、「ピクノジェノール」(ホーファー・リサーチ社
製)等が市販されている。
As described above, the extract from grape seeds is an extract obtained by extracting grape seeds with a hydrophilic organic solvent such as ethanol or a water-containing solvent thereof, and is commercially available as "Activin" (Interhealth). Company),
"KPA-40" (manufactured by Kikkoman Corp.), "Grape seed extract" (manufactured by Farmline)
And the like, but the present invention is not limited by these. The extract from the bark of French pine pine is also an extract obtained by extraction with a hydrophilic organic solvent such as ethanol or this water-containing solvent as described above, such as "Pycnogenol" (manufactured by Hofer Research). It is commercially available.

【0017】次に、本発明の過酸化脂質抑制剤の製造法
は、グアバの葉を、水もしくは親水性有機溶媒またはこ
れらの混合溶媒を用いて、1.2〜5気圧の加圧下かつ
加熱下で抽出して得られるエキスを有効成分として含有
せしめることを特徴とするものである。
Next, the method for producing the lipid peroxide inhibitor of the present invention comprises the steps of: applying guava leaves to water or a hydrophilic organic solvent or a mixed solvent thereof under a pressure of 1.2 to 5 atm and heating. An extract obtained by extraction below is contained as an active ingredient.

【0018】この製造法においては、抽出処理を1.2
〜5気圧の加圧下かつ加熱下で行うことが重要である。
当然のことながら、常温、常圧でも抽出エキスを得るこ
とは可能であるが、前記条件下、さらに好ましくは1.
2〜1.7気圧の加圧下かつ100〜130℃の加熱下
で抽出処理して得られるエキスが過酸化脂質抑制効果に
優れ、本発明の過酸化脂質抑制剤を製造する上で有利で
ある。なお、グアバの葉、親水性有機溶媒や混合溶媒の
種類と混合比率、抽出方法および乾燥、粉末化方法等は
前述と同じである。
In this manufacturing method, the extraction process is performed in a manner similar to that of 1.2.
It is important to carry out under a pressure of 〜5 atm and under heating.
As a matter of course, it is possible to obtain the extract at normal temperature and normal pressure, but under the above conditions, more preferably 1.
An extract obtained by performing an extraction treatment under a pressure of 2 to 1.7 atm and under a heating of 100 to 130 ° C. has an excellent lipid peroxide inhibitory effect, and is advantageous in producing the lipid peroxide inhibitor of the present invention. . The types and mixing ratios of the guava leaves, the hydrophilic organic solvent and the mixed solvent, the extraction method, and the drying and powdering methods are the same as those described above.

【0019】さらに、本発明は前記過酸化脂質抑制剤を
配合してなる組成物を提供するものである。すなわち、
前述のようにして得られるグアバ葉の抽出エキスを有効
成分として含有してなる過酸化脂質抑制剤は、これをそ
のまま液状、ゲル状あるいは固形状の食品に添加した
り、適宜にデキストリン等の賦型剤、香料、色素等とと
もにペレット、錠剤、顆粒、またゼラチン等で被覆して
カプセルに成形した健康食品に加工したり、クリーム、
乳液、口紅等の化粧品に配合したり、軟膏などの医薬品
や農薬等の各種組成物を製造する際に配合して、過酸化
脂質の生成が抑制され、酸化安定性に優れた前記各種組
成物を提供する。組成物としては食品が好適である。こ
れらの組成物における本発明の過酸化脂質抑制剤の配合
量は、組成物の種類や状態等により一律に規定しがたい
が、概ね0.001〜30重量%、より好ましくは0.
01〜10重量%である。なお、本発明の過酸化脂質抑
制剤を例えば粉末状のまま食用に供しても何らさしつか
えない。
Further, the present invention provides a composition comprising the above-mentioned lipid peroxide inhibitor. That is,
The lipid peroxide inhibitor containing the extract of guava leaf obtained as described above as an active ingredient can be added as it is to a liquid, gel-like or solid food, or can be appropriately treated with dextrin or the like. Pellets, tablets, granules, as well as molds, flavors, pigments, etc.
Emulsions, blended in cosmetics such as lipsticks, or blended when manufacturing various compositions such as ointments and other pharmaceuticals and agricultural chemicals, the production of lipid peroxides is suppressed, and the various compositions excellent in oxidative stability I will provide a. Food is suitable as the composition. The amount of the lipid peroxide inhibitor of the present invention in these compositions cannot be uniformly defined depending on the type and condition of the composition, but is generally about 0.001 to 30% by weight, more preferably about 0.1 to 30% by weight.
01 to 10% by weight. It should be noted that the lipid peroxide inhibitor of the present invention may be used for food in powder form, for example, without any problem.

【0020】[0020]

【実施例】【Example】

実施例1 グアバの乾燥葉100kgを約2〜5mm角サイズに砕
片化して加圧式抽出釜(1500リットル)に仕込み、
水600リットルを加え、釜内温度が120℃になるま
で加熱し、釜内圧力を1.3±0.1気圧にして45分
間抽出した。ついで残渣をフィルタープレスで除き、抽
出液を減圧濃縮機で処理して濃縮物(Brix30)9
5リットルを得た。該濃縮物をさらにスプレードライヤ
ーで処理して乾燥、粉末化し、うす茶色の粉末グアバ葉
抽出エキス(試料1)27kgを得た。
Example 1 100 kg of dried guava leaves were crushed into a size of about 2 to 5 mm square and charged in a pressurized extraction kettle (1500 liters).
600 liters of water was added, the mixture was heated until the temperature in the kettle became 120 ° C., and the pressure in the kettle was set to 1.3 ± 0.1 atm. Then, the residue was removed with a filter press, and the extract was treated with a vacuum concentrator to obtain a concentrate (Brix 30) 9
5 liters were obtained. The concentrate was further processed by a spray drier to dry and powder, and 27 kg of light brown powdered guava leaf extract (sample 1) was obtained.

【0021】実施例2 グアバの乾燥葉100kgを約2〜5mm角サイズに粉
砕して加圧式抽出釜(1500リットル)に仕込み、ア
ルコール濃度が30重量%の含水エタノール500リッ
トルを加え、釜内温度:75℃、釜内圧力:1.6±
0.1気圧に設定して30分間抽出した。ついで、残渣
をフィルタープレスで除き、抽出液を減圧濃縮機で処理
して濃縮物(Brix32)96リットルを得た。該濃
縮物をさらにフリーズドライヤーで処理して乾燥、粉末
化し、うす茶色の粉末グアバ葉抽出エキス(試料2)3
0kgを得た。
Example 2 100 kg of dried guava leaves were crushed to a size of about 2 to 5 mm square and charged into a pressure-type extraction kettle (1500 liter), and 500 liters of aqueous ethanol having an alcohol concentration of 30% by weight was added. : 75 ° C, pressure in the pot: 1.6 ±
Extraction was performed for 30 minutes at 0.1 atm. Subsequently, the residue was removed with a filter press, and the extract was treated with a vacuum concentrator to obtain 96 liters of a concentrate (Brix32). The concentrate is further treated with a freeze dryer, dried and powdered, and light brown powdered guava leaf extract (sample 2) 3
0 kg was obtained.

【0022】実施例3 実施例2において、アルコール濃度が50重量%の含水
エタノール500リットルを使用する以外は同様に処理
して、うす茶色の粉末グアバ葉抽出エキス(試料3)2
9kgを得た。
Example 3 Light brown guava leaf extract (sample 3) was treated in the same manner as in Example 2 except that 500 liters of aqueous ethanol having an alcohol concentration of 50% by weight was used.
9 kg were obtained.

【0023】実施例4 実施例2において、アルコール濃度が80重量%の含水
エタノール500リットルを使用する以外は同様に処理
して、うす茶色の粉末グアバ葉抽出エキス(試料4)2
9kgを得た。
Example 4 A light brown powdered guava leaf extract (sample 4) was prepared in the same manner as in Example 2 except that 500 liters of aqueous ethanol having an alcohol concentration of 80% by weight was used.
9 kg were obtained.

【0024】比較例1 実施例1において釜内温度を25℃、釜内圧力を1気圧
に設定する以外は同様に処理し、うす茶色の粉末グアバ
葉抽出エキス(比較試料1)23kgを得た。
Comparative Example 1 The procedure of Example 1 was repeated, except that the temperature in the kettle was set to 25 ° C. and the pressure in the kettle was set to 1 atm, to obtain 23 kg of light brown powdered guava leaf extract (Comparative sample 1). .

【0025】比較例2 実施例3において釜内温度を25℃、釜内圧力を1気圧
に設定する以外は同様に処理し、うす茶色の粉末グアバ
葉抽出エキス(比較試料2)25kgを得た。
Comparative Example 2 The same treatment as in Example 3 was carried out except that the temperature in the kettle was set to 25 ° C. and the pressure in the kettle was set to 1 atm, to obtain 25 kg of a light brown powdered guava leaf extract (Comparative Sample 2). .

【0026】上記実施例および比較例で調製した各グア
バ葉抽出エキスの過酸化脂質抑制活性を以下の方法で試
験した。 試験例1(ラット肝ミトコンドリア画分での過酸化脂質
生成抑制活性) Wistar系ラット(6週齢、体重160g)を屠殺
し、速やかに肝臓(10g)を摘出した後、3mMトリ
スおよび0.1mM EDTA含有の0.25Mシュク
ロース液(pH7.4)100mlでホモジネートし
た。このホモジネート液を4℃で10分間、2,000
rpmで遠心分離し、その上清をさらに17,000r
pmで40分間遠心分離してミトコンドリア画分を得
た。ミトコンドリア画分をDulbeccoリン酸緩衝
生理食塩水(pH7.4)に懸濁させ、タンパク質含量
を6mg/mlに調整した。ついで、この懸濁液100
μlに40mM ADP(アデノシンニリン酸)20μ
l、12mMアスコルビン酸20μl、および被験物質
(実施例1〜4および比較例1、2で調製した各グアバ
葉抽出エキス、フランス海岸松の樹皮からの抽出エキス
(商品名:ピクノジェノール、ホーファー・リサーチ社
製)、ブドウ種子からの抽出エキス(商品名:KPA−
40、キッコーマン(株)製)、リンゴ種子からの抽出
エキス(商品名:アップルフェノン粉末50、ニッカウ
イスキー(株)製)、これらの混合物、タンニン成分で
あるペンタ−O−ガロイルグルコース(試薬)の各々を
Dulbeccoリン酸緩衝生理食塩水(pH7.4)
に溶解させたもの)を添加し、37℃で1時間インキュ
ベートして反応させ、生じた過酸化脂質量を八木法によ
って測定した。なお、過酸化脂質量はタンパク質1mg
当たりのマロンジアルデヒド量として表示した。この結
果を表1に示す。
Each of the guava leaf extracts prepared in the above Examples and Comparative Examples was tested for its lipid peroxide inhibiting activity by the following method. Test Example 1 (Lipid Peroxidation Inhibition Activity in Rat Liver Mitochondrial Fraction) Wistar rats (6 weeks old, body weight 160 g) were sacrificed, liver (10 g) was immediately removed, and then 3 mM Tris and 0.1 mM The mixture was homogenized with 100 ml of a 0.25 M sucrose solution (pH 7.4) containing EDTA. This homogenate solution is added at 2,000 for 10 minutes at 4 ° C.
After centrifugation at rpm, the supernatant was further
Centrifugation at pm for 40 minutes gave the mitochondrial fraction. The mitochondrial fraction was suspended in Dulbecco's phosphate buffered saline (pH 7.4) and the protein content was adjusted to 6 mg / ml. Then, this suspension 100
20 μl of 40 mM ADP (adenosine diphosphate) in μl
1, 12 mM ascorbic acid 20 μl, and test substances (Guava leaf extract prepared in Examples 1 to 4 and Comparative Examples 1 and 2, extract from bark of French pine pine (trade name: Pycnogenol, Hofer Research Co., Ltd.) Extract from grape seeds (trade name: KPA-
40, manufactured by Kikkoman Corporation), an extract from apple seeds (trade name: Applephenon Powder 50, manufactured by Nikka Whiskey Co., Ltd.), a mixture thereof, and tannin component penta-O-galloylglucose (reagent). Each is Dulbecco's phosphate buffered saline (pH 7.4)
Was added thereto, and incubated at 37 ° C. for 1 hour to react. The amount of lipid peroxide generated was measured by the Yagi method. The amount of lipid peroxide was 1 mg of protein.
It was expressed as the amount of malondialdehyde per unit. Table 1 shows the results.

【0027】表1から、全ての被験物質の添加により、
肝ミトコンドリア画分におけるADPおよびアスコルビ
ン酸の誘導による過酸化脂質の生成が抑制されたが、各
被験物質ごとの活性は、本発明に係るグアバ葉抽出エキ
ス(試料1〜4)の場合に優れており、また、本発明に
係るグアバ葉抽出エキスと、海岸松の樹皮からの抽出エ
キス、ブドウ種子からの抽出エキスまたはリンゴ種子か
らの抽出エキスとを併用した場合には過酸化脂質生成抑
制活性が極めて高いことが認められた。
From Table 1, it can be seen that by adding all the test substances,
Although the production of lipid peroxide due to the induction of ADP and ascorbic acid in the liver mitochondrial fraction was suppressed, the activity of each test substance was superior to that of the guava leaf extract (samples 1 to 4) according to the present invention. In addition, when the guava leaf extract according to the present invention and an extract from the bark of shore pine, an extract from grape seeds or an extract from apple seeds are used in combination, the lipid peroxide production inhibitory activity is reduced. It was found to be very high.

【0028】[0028]

【表1】 [Table 1]

【0029】注1:表中の数値は、過酸化脂質の生成量
をタンパク質1mg当たりのマロンジアルデヒド量(n
mol)として示したものである。被験物質が混合の場
合の比は重量比である。 注2:緩衝液に懸濁させた肝ミトコンドリア画分にAD
Pおよびアスコルビン酸のみを添加したときの過酸化脂
質量。 注3:ホーファー リサーチ社製、商品名「ピクノジェ
ノール」。 注4:キッコーマン(株)製、商品名「KPA−4
0」。 注5:ニッカウイスキー(株)製、商品名「アップルフ
ェノン粉末50」。 注6:ペンタ−O−ガロイルグルコース(試薬)。
Note 1: The numerical values in the table represent the amount of lipid peroxide produced in terms of the amount of malondialdehyde per mg of protein (n
mol). When the test substances are mixed, the ratio is a weight ratio. Note 2: AD is added to the liver mitochondrial fraction suspended in the buffer.
The amount of lipid peroxide when only P and ascorbic acid were added. Note 3: "Pycnogenol" manufactured by Hofer Research. Note 4: “KPA-4” manufactured by Kikkoman Corporation
0 ". Note 5: Nikka Whiskey Co., Ltd. product name "Applephenon Powder 50". Note 6: Penta-O-galloyl glucose (reagent).

【0030】試験例2(ラット肝ミクロソーム画分での
過酸化脂質生成抑制活性) 試験例1に記載の方法において、ミトコンドリア画分を
遠心分離した後の上清液をさらに34,000rpmで
1時間遠心分離し、ミクロソーム画分を得た。これをD
ulbeccoリン酸緩衝生理食塩水(pH7.4)に
懸濁させ、タンパク質含量を6mg/mlに調整した。
ついで、この懸濁液100μlに40mM ADP20
μl、4mM NADPH(還元型ニコチンアミドアデ
ニンジヌクレオチドリン酸)20μl、および試験例1
と同じ被験物質をそれぞれDulbeccoリン酸緩衝
生理食塩水(pH7.4)に溶解させたものを添加し、
37℃で1時間インキュベートして反応させ、生じた過
酸化脂質量を試験例1に記載の方法で測定した。過酸化
脂質量はタンパク質1mg当たりのマロンジアルデヒド
量として表示した。この結果を表2に示す。
Test Example 2 (Lipid peroxide production inhibitory activity in rat liver microsomal fraction) In the method described in Test Example 1, the supernatant obtained after centrifuging the mitochondrial fraction was further subjected to 34,000 rpm for 1 hour. After centrifugation, a microsomal fraction was obtained. This is D
It was suspended in ulbecco phosphate buffered saline (pH 7.4) and the protein content was adjusted to 6 mg / ml.
Next, 100 μl of this suspension was added with 40 mM ADP20.
μl, 4 mM NADPH (reduced nicotinamide adenine dinucleotide phosphate) 20 μl, and Test Example 1
Each of the same test substances dissolved in Dulbecco's phosphate buffered saline (pH 7.4) was added.
The reaction was carried out by incubating at 37 ° C. for 1 hour, and the amount of generated lipid peroxide was measured by the method described in Test Example 1. The amount of lipid peroxide was expressed as the amount of malondialdehyde per mg of protein. Table 2 shows the results.

【0031】表2において、被験物質を添加した場合は
いずれも500μg/mlおよび100μg/ml濃度
の添加によって、肝ミクロソーム画分におけるADPお
よびNADPHの誘導による過酸化脂質の生成が抑制さ
れることが明らかになった。また、各被験物質ごとの活
性を比較すると、本発明に係るグアバ葉抽出エキス(試
料1〜4)の場合に過酸化脂質の生成が強く抑制され、
その活性はタンニン成分ペンタ−O−ガロイルグルコー
スと同程度であり、本発明に係るグアバ葉抽出エキスと
海岸松の樹皮からの抽出エキス、ブドウ種子からの抽出
エキスまたはリンゴ種子からの抽出エキスとを併用した
場合には、過酸化脂質の生成がさらに強く阻害される相
乗効果が認められた。
In Table 2, it can be seen that the addition of the test substances in all cases resulted in suppression of the production of lipid peroxide due to the induction of ADP and NADPH in the liver microsomal fraction by addition of the concentrations of 500 μg / ml and 100 μg / ml. It was revealed. In addition, comparing the activity of each test substance, the production of lipid peroxide is strongly suppressed in the case of the guava leaf extract (samples 1 to 4) according to the present invention,
Its activity is about the same as that of the tannin component penta-O-galloyl glucose, and the guava leaf extract and the extract from the pine bark of the present invention, the extract from grape seeds or the extract from apple seeds according to the present invention. When used in combination, a synergistic effect in which the production of lipid peroxide was more strongly inhibited was observed.

【0032】[0032]

【表2】 [Table 2]

【0033】注1、3〜6:表1の注釈と同じ。 注2:緩衝液に懸濁させた肝ミクロソーム画分にADP
およびNADPHのみを添加したときの過酸化脂質量。
Notes 1, 3 to 6: Same as the notes in Table 1. Note 2: ADP is added to the liver microsome fraction suspended in the buffer.
And the amount of lipid peroxide when only NADPH was added.

【0034】試験例3 本発明に係るグアバ葉抽出エキスの魚油に対する酸化防
止作用を調べた。すなわち、100mlビーカーに魚油
50mlを入れ、実施例1〜4および比較実施例1、2
で得たグアバ葉抽出エキス(試料1〜4および比較試料
1、2)のいずれか1種が100ppm濃度となるよう
に添加し、室温にて開放状態で静置し、、日本油化学協
会編「基準油脂分析試験法」に記載の方法に準じて経時
的に過酸化物価を測定した。なお、同時にトコフェロー
ルを1000ppmまたは100ppm添加した比較試
験を行った。この結果、トコフェロール1000ppm
添加物では試験開始後4時間目に、また同100ppm
添加物では10時間目にそれぞれ過酸化物が検出され、
12時間目の過酸化物価はそれぞれ73、48であっ
た。これに対して試料1〜4および比較試料1、2を添
加した場合にはいずれも過酸化物価として検出されなか
った。
Test Example 3 The antioxidant effect of the guava leaf extract according to the present invention on fish oil was examined. That is, 50 ml of fish oil was put into a 100 ml beaker, and Examples 1 to 4 and Comparative Examples 1 and 2 were added.
One of the guava leaf extract (samples 1 to 4 and comparative samples 1 and 2) obtained in step 1 was added to a concentration of 100 ppm, and the mixture was allowed to stand at room temperature in an open state. The peroxide value was measured over time according to the method described in "Standard Fat and Oil Analysis Test Method". At the same time, a comparative test in which tocopherol was added at 1000 ppm or 100 ppm was performed. As a result, tocopherol 1000 ppm
4 hours after the start of the test, 100 ppm
In the additive, peroxide was detected respectively at 10 hours,
The peroxide values at 12 hours were 73 and 48, respectively. On the other hand, when Samples 1 to 4 and Comparative Samples 1 and 2 were added, none was detected as a peroxide value.

【0035】実施例5 実施例1で得たグアバ葉抽出エキス5.0kg、化工澱
粉(松谷化学(株)製、商品名:パインフロー)3.5
kg、第三リン酸カルシウム0.3kg、ビタミンB
0.3kg、ビタミンB0.3kg、ビタミンB
0.2kgおよびビタミンC0.4kgを配合機に仕
込み、10分間攪拌して取り出し、直打式打錠機に供給
して直径7mm、長さ4mm、重量150mgのペレッ
トを作成した後、コーティング機でセラック薄膜をコー
ティングしてペレット状食品を試作した。このペレット
は1個あたりグアバ葉抽出エキスを75mgを含む。ま
た、実施例2〜4で得たグアバ葉抽出エキスを用いて同
様に処理し、ペレット1個あたりグアバ葉抽出エキスを
20mg、50mgまたは150mg含むペレット状食
品を試作した。なお、グアバ葉抽出エキスの配合量の増
減はパインフローの配合量で調整した。これらを30℃
の恒温室で6ヵ月間保存後試食したが、いずれの風味も
試作直後のものと同様であった。
Example 5 5.0 kg of the guava leaf extract obtained in Example 1 and 3.5 g of chemically modified starch (Pine Flow, manufactured by Matsutani Chemical Co., Ltd.)
kg, tricalcium phosphate 0.3 kg, vitamin B 1
0.3 kg, vitamin B 2 0.3 kg, vitamin B
6 0.2 kg of vitamin C and 0.4 kg of vitamin C were charged into a compounding machine, stirred for 10 minutes, taken out, and supplied to a direct compression tableting machine to form pellets having a diameter of 7 mm, a length of 4 mm, and a weight of 150 mg. A shell-like thin film was coated by using to produce a pelletized food product. Each of the pellets contains 75 mg of guava leaf extract. Further, the same treatment was performed using the guava leaf extract obtained in Examples 2 to 4, and pelletized foods containing 20 mg, 50 mg or 150 mg of the guava leaf extract per pellet were produced. The amount of the guava leaf extract was increased or decreased by adjusting the amount of the pine flow. 30 ° C
After being stored in a constant temperature room for 6 months, the samples were tasted, and all flavors were the same as those immediately after the trial production.

【0036】実施例6 大豆油および菜種油の調合油400g、大豆硬化油35
0gおよびパーム油100gの混合油と、水100m
l、実施例3で得たグアバ葉抽出エキス15g、乳固形
分15g、食塩14g、ステアリン酸モノグリセリド3
g、大豆レシチン2g、β−カロチンおよび乳フレーバ
ー各少量とを乳化させた後、急速練り合わせ処理をし、
グアバ葉抽出エキス入りマーガリンを試作した。
Example 6 400 g of a blended oil of soybean oil and rapeseed oil, 35 soybean hardened oil
0 g and a mixed oil of 100 g of palm oil and 100 m of water
1, 15 g of guava leaf extract obtained in Example 3, 15 g of milk solids, 14 g of common salt, monoglyceride stearic acid 3
g, 2 g of soy lecithin, β-carotene and a small amount of milk flavor, respectively, and then emulsified, followed by rapid kneading,
A guava leaf extract-containing margarine was prototyped.

【0037】実施例7 バター100g、ショートニング200g、牛乳30g
および砂糖60gを家庭用ホイッパーでよく攪拌しなが
ら鶏卵60gを加えて十分に混合した後、小麦粉300
g、ベーキングパウダー1.5gおよび実施例1〜4で
得たグアバ葉抽出エキスのいずれか5gの混合粉体を加
えてさらに混捏した。このドウを30分間ねかせた後、
金型で50個に分割し、オーブンで焼いてバタークッキ
ーを試作した。
Example 7 100 g of butter, 200 g of shortening, 30 g of milk
60 g of sugar and 60 g of hen's egg were added and mixed well while stirring well with a household whipper.
g, 1.5 g of baking powder and a mixed powder of 5 g of the guava leaf extract obtained in Examples 1 to 4 were further added and kneaded. After letting this dough for 30 minutes,
It was divided into 50 pieces by a mold and baked in an oven to produce a prototype of butter cookies.

【0038】実施例8 市販のグレープジュース100mlに、実施例1〜4で
得たグアバ葉抽出エキス(試料1〜4)のいずれか1
種:ブドウ種子抽出エキス(インターヘルス社製、商品
名「アクティビン」)=1:1(重量比)を加え、攪拌
して溶解させ、グアバ葉抽出エキスすなわち試料1を
0.01重量%、試料2を0.1重量%、試料3を0.
7重量%、試料4を1.5重量%それぞれ含むグアバ葉
抽出エキス入りジュースを調製した。これらの風味およ
び保存性はいずれも無添加のグレープジュースと同様あ
るいはそれ以上であった。
Example 8 One of the guava leaf extracts (samples 1 to 4) obtained in Examples 1 to 4 was added to 100 ml of commercially available grape juice.
Species: Grape seed extract (manufactured by Inter Health, trade name “Activin”) = 1: 1 (weight ratio) was added and dissolved by stirring, and guava leaf extract, ie, sample 1 was 0.01% by weight, 0.1% by weight of sample 2 and 0.1% by weight of sample 3
A juice containing an extract of guava leaf extract containing 7% by weight and 1.5% by weight of Sample 4 was prepared. All of these flavors and storability were similar to or higher than the grape juice without additives.

【0039】実施例9 流動パラフィン100g、ホホバ油40g、スクワラン
30g、オリーブ油30g、ステアリン酸30g、ステ
アリン酸モノグリセリド(理研ビタミン(株)製、商品
名:エマルジーMS)30g、ソルビタン脂肪酸エステ
ル(花王(株)製、エマゾールS−10F)10gおよ
びブチルパラベン1gを混合して油相とし80℃に保持
した。一方、精製水655mlにグリセリン22g、
1,3−ブチレングリコール20g、エチルパラベン2
gおよび実施例3で得たグアバ葉抽出エキス30gを8
0℃まで加熱しながら混合して水相とし同温に保ち、攪
拌しながら前記油相を徐々に加えて均質に乳化させた。
この乳化物を引き続き攪拌しながら室温になるまで冷却
して化粧用クリームを試作した。また、比較のため、前
記処方でグアバ葉抽出エキスを配合せず、精製水を68
5ml使用する以外は同条件でクリームを調製した。両
クリームの一部をガラス製褐色瓶に入れ、蓋をして室内
(20〜30℃)で1ヵ月間放置後、ヘキサンを用いて
油分を抽出し、その過酸化物価を測定したところ、比較
のためのクリームでは73であったが、本発明のクリー
ムでは2であった。
Example 9 100 g of liquid paraffin, 40 g of jojoba oil, 30 g of squalane, 30 g of olive oil, 30 g of stearic acid, 30 g of monoglyceride stearic acid (trade name: Emulgy MS, manufactured by Riken Vitamin Co., Ltd.), 30 g of sorbitan fatty acid ester (Kao Co., Ltd.) ), And 10 g of Emazole S-10F) and 1 g of butylparaben were mixed to form an oil phase, which was maintained at 80 ° C. On the other hand, 22 g of glycerin was added to 655 ml of purified water,
1,3-butylene glycol 20 g, ethyl paraben 2
g and 30 g of the guava leaf extract obtained in Example 3 in 8
The mixture was heated to 0 ° C. while mixing to obtain an aqueous phase, kept at the same temperature, and the oil phase was gradually added thereto with stirring to homogenize the mixture.
The emulsion was cooled to room temperature with continuous stirring to produce a cosmetic cream. For comparison, guava leaf extract was not added in the above formulation, and purified water
A cream was prepared under the same conditions except that 5 ml was used. A part of both creams was placed in a glass brown bottle, covered and left indoors (20-30 ° C) for one month. Oil was extracted with hexane and its peroxide value was measured. Was 73 for the cream for the present invention and 2 for the cream of the present invention.

【0040】[0040]

【発明の効果】本発明によれば、グアバの葉から抽出さ
れるエキスを含有してなり、各種工業製品のみならず生
体内における過酸化脂質の生成をも抑制し、強力な抗酸
化活性を有する、安全な過酸化脂質生成抑制剤が提供さ
れる。この抑制剤の効果は、前記グアバ葉抽出エキス
と、ブドウ種子からの抽出エキスおよび/またはフラン
ス海岸松の樹皮からの抽出エキスとを併用することによ
ってさらに顕著なものとなる。また、本発明では、グア
バの葉を、水もしくはエタノール等の親水性有機溶媒ま
たはこれらの混合溶媒を用いて、加圧下かつ加熱下で抽
出することによって、過酸化脂質の生成をより一層強く
抑制するグアバ葉抽出エキスが得られ、これを有効成分
として含有してなる過酸化脂質生成抑制剤の製造法が提
供できる。さらに、本発明によれば、過酸化脂質の生成
がほぼ完全に抑制され、酸化安定性に優れた食品、化粧
品、農薬、医薬品等の組成物が提供される。とりわけ生
体内での過酸化脂質生成抑制作用が顕著であることか
ら、肝臓障害、動脈硬化症、血栓症等の予防剤あるいは
治療剤としての利用が可能である。
Industrial Applicability According to the present invention, it contains an extract extracted from guava leaves, suppresses not only the production of various industrial products but also the production of lipid peroxide in vivo, and has a strong antioxidant activity. And a safe lipid peroxide production inhibitor. The effect of this inhibitor becomes even more remarkable when the guava leaf extract is used in combination with an extract from grape seeds and / or an extract from the bark of French pine pine. In the present invention, the production of lipid peroxide is more strongly suppressed by extracting guava leaves under pressure and heating using a hydrophilic organic solvent such as water or ethanol or a mixed solvent thereof. A guava leaf extract is obtained, and a method for producing a lipid peroxide production inhibitor containing the extract as an active ingredient can be provided. Further, according to the present invention, there are provided compositions for foods, cosmetics, agricultural chemicals, pharmaceuticals, and the like, in which the production of lipid peroxide is almost completely suppressed and which has excellent oxidation stability. In particular, since the inhibitory effect of lipid peroxide production in vivo is remarkable, it can be used as a preventive or therapeutic agent for liver damage, arteriosclerosis, thrombosis and the like.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI // A21D 13/08 A21D 13/08 A23D 7/06 500 A23D 7/06 500 A23G 3/00 102 A23G 3/00 102 A23L 2/52 A23L 2/00 F ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification symbol FI // A21D 13/08 A21D 13/08 A23D 7/06 500 A23D 7/06 500 A23G 3/00 102 A23G 3/00 102 A23L 2 / 52 A23L 2/00 F

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】 グアバの葉を、水もしくは親水性有機溶
媒またはこれらの混合溶媒を用いて抽出して得られるエ
キスを有効成分として含有してなる過酸化脂質生成抑制
剤。
1. A lipid peroxide production inhibitor comprising, as an active ingredient, an extract obtained by extracting guava leaves with water or a hydrophilic organic solvent or a mixed solvent thereof.
【請求項2】 抽出を1.2〜5気圧の加圧下かつ加熱
下で行うものである請求項1に記載の抑制剤。
2. The inhibitor according to claim 1, wherein the extraction is carried out under a pressure of 1.2 to 5 atm and under heating.
【請求項3】 抽出を1.2〜1.7気圧の加圧下、1
00〜130℃の加熱下で行うものである請求項2に記
載の抑制剤。
3. The extraction is carried out under a pressure of 1.2 to 1.7 atm.
The inhibitor according to claim 2, which is carried out under heating at 00 to 130 ° C.
【請求項4】 植物体からの抽出エキスであり、プロア
ントシアニジンを含む前記抽出エキスをさらに含有して
なる請求項1〜3のいずれか1項に記載の抑制剤。
4. The inhibitor according to any one of claims 1 to 3, which is an extract from a plant, further comprising the extract containing proanthocyanidin.
【請求項5】 プロアントシアニジンを含む抽出エキス
がブドウ種子からの抽出エキスおよび/またはフランス
海岸松(Pinus pinaster)の樹皮からの
抽出エキスである請求項4に記載の抑制剤。
5. The inhibitor according to claim 4, wherein the extract containing proanthocyanidins is an extract from grape seeds and / or an extract from bark of French pine (Pinus pinaster).
【請求項6】 グアバの葉を、水もしくは親水性有機溶
媒またはこれらの混合溶媒を用い、1.2〜5気圧の加
圧下かつ加熱下で抽出して得られるエキスを有効成分と
して含有せしめることを特徴とする過酸化脂質生成抑制
剤の製造法。
6. An extract obtained by extracting guava leaves using water or a hydrophilic organic solvent or a mixed solvent thereof under a pressure of 1.2 to 5 atm and under heating, as an active ingredient. A method for producing a lipid peroxide production inhibitor, characterized by comprising:
【請求項7】 抽出を1.2〜1.7気圧の加圧下、1
00〜130℃の加熱下で行うものである請求項6に記
載の製造法。
7. The extraction is carried out under a pressure of 1.2 to 1.7 atm.
The method according to claim 6, wherein the method is performed under heating at 00 to 130 ° C. 8.
【請求項8】 請求項1〜5のいずれか1項に記載の抑
制剤を配合してなる組成物。
8. A composition comprising the inhibitor according to any one of claims 1 to 5.
【請求項9】 食品である請求項8に記載の組成物。9. The composition according to claim 8, which is a food.
JP9285949A 1997-09-09 1997-09-09 Peroxylipid production inhibitor, its production and utulization thereof Pending JPH1175770A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9285949A JPH1175770A (en) 1997-09-09 1997-09-09 Peroxylipid production inhibitor, its production and utulization thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9285949A JPH1175770A (en) 1997-09-09 1997-09-09 Peroxylipid production inhibitor, its production and utulization thereof

Publications (1)

Publication Number Publication Date
JPH1175770A true JPH1175770A (en) 1999-03-23

Family

ID=17698060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9285949A Pending JPH1175770A (en) 1997-09-09 1997-09-09 Peroxylipid production inhibitor, its production and utulization thereof

Country Status (1)

Country Link
JP (1) JPH1175770A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226289A (en) * 2000-02-16 2001-08-21 Snow Brand Milk Prod Co Ltd Hepatic function ameliorative agent
JP2002275076A (en) * 2001-03-15 2002-09-25 Toyo Shinyaku:Kk Inhibitor of elevation of glycemia and healthy food
JP2003290603A (en) * 2002-03-29 2003-10-14 National Institute Of Advanced Industrial & Technology Recovery method for polyflavonoid from woody bark
JP2006056793A (en) * 2004-08-18 2006-03-02 Bizen Chemical Co Ltd Method for producing polyphenol-containing product, polyphenol-containing product, alpha amylase inhibitor, antioxidant, and edible composition
WO2007135767A1 (en) 2006-05-18 2007-11-29 Kabushiki Kaisha Yakult Honsha Guava leaf extract powder and method for production thereof
US20090074897A1 (en) * 2005-07-12 2009-03-19 Kabushiki Kaisha Yakult Honsha Agent for elevating adiponectin concentration
WO2010058795A1 (en) 2008-11-19 2010-05-27 森永乳業株式会社 Antioxidant
WO2011083586A1 (en) * 2010-01-07 2011-07-14 株式会社 エコビジネス Combination food material of dairy product containing polyphenol component extract obtained by extracting guava leaves
US8486899B2 (en) 2008-11-19 2013-07-16 Morinaga Milk Industry Co., Ltd. Antioxidant
JP2018028067A (en) * 2016-08-15 2018-02-22 アサヒビール株式会社 Product containing pinene and pinene conversion composition converting pinene into terpinolene, and pinene conversion composition, pinene-containing flavor composition and product containing the same

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4679687B2 (en) * 2000-02-16 2011-04-27 雪印乳業株式会社 Liver function improving agent
JP2001226289A (en) * 2000-02-16 2001-08-21 Snow Brand Milk Prod Co Ltd Hepatic function ameliorative agent
JP2002275076A (en) * 2001-03-15 2002-09-25 Toyo Shinyaku:Kk Inhibitor of elevation of glycemia and healthy food
JP2003290603A (en) * 2002-03-29 2003-10-14 National Institute Of Advanced Industrial & Technology Recovery method for polyflavonoid from woody bark
JP2006056793A (en) * 2004-08-18 2006-03-02 Bizen Chemical Co Ltd Method for producing polyphenol-containing product, polyphenol-containing product, alpha amylase inhibitor, antioxidant, and edible composition
EP1902722B1 (en) * 2005-07-12 2020-12-16 Kabushiki Kaisha Yakult Honsha Agent for elevating adiponectin concentration
US20090074897A1 (en) * 2005-07-12 2009-03-19 Kabushiki Kaisha Yakult Honsha Agent for elevating adiponectin concentration
US8021699B2 (en) 2006-05-18 2011-09-20 Kabushiki Kaisha Yakult Honsha Guava leaf extract powder and method for production thereof
WO2007135767A1 (en) 2006-05-18 2007-11-29 Kabushiki Kaisha Yakult Honsha Guava leaf extract powder and method for production thereof
WO2010058795A1 (en) 2008-11-19 2010-05-27 森永乳業株式会社 Antioxidant
US8470807B2 (en) 2008-11-19 2013-06-25 Morinaga Milk Industry Co., Ltd. Antioxidant
US8486899B2 (en) 2008-11-19 2013-07-16 Morinaga Milk Industry Co., Ltd. Antioxidant
WO2011083586A1 (en) * 2010-01-07 2011-07-14 株式会社 エコビジネス Combination food material of dairy product containing polyphenol component extract obtained by extracting guava leaves
JP2018028067A (en) * 2016-08-15 2018-02-22 アサヒビール株式会社 Product containing pinene and pinene conversion composition converting pinene into terpinolene, and pinene conversion composition, pinene-containing flavor composition and product containing the same

Similar Documents

Publication Publication Date Title
Guo et al. A review of phytochemistry, metabolite changes, and medicinal uses of the common sunflower seed and sprouts (Helianthus annuus L.)
JP4744447B2 (en) Gnetsum extract
Bozan et al. Antioxidant and free radical scavenging activities of Rhus coriaria and Cinnamomum cassia extracts
Gomathy et al. Comparison of antioxidant potential in pulp and peel extracts of Manilkara zapota (L.) P. Royen
JP2015514435A (en) Method of using arabinogalactan in combination with dietary ingredients dihydroquercetin (taxifolin), arabinogalactan and dihydroquercetin (taxifolin) for application to food
JP3635081B2 (en) Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods
Akomolafe et al. Inhibitory effect of aqueous extract of Moringa oleifera and Newbuoldia laevis leaves on ferrous sulphate and sodium nitroprusside induced oxidative stress in rat’s testes in vitro
JP2001200250A (en) Antioxidant
JPH1175770A (en) Peroxylipid production inhibitor, its production and utulization thereof
KR102269270B1 (en) Method for producing extracts of sweet potato with enhanced antioxidative activity
Görgüç et al. Industrial pomegranate wastes and their functional benefits in novel food formulations
JP2004352639A (en) Active oxygen scavenger and its composition
KR100478136B1 (en) Extracts derived from plant that have anti-oxidation activity
JP2005200360A (en) Active oxygen scavenger derived from natural product and application thereof
CN113613508A (en) Antioxidant composition comprising quercitrin and gallic acid
LC Albuquerque et al. Trends in annatto agroindustry: Bixin processing technologies and market
EP3082464B1 (en) Composition comprising grape extracts, the extraction method and its uses
AU2008306838A1 (en) Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants
JP2008013481A (en) Tyrosinase activity inhibitor and lipoxygenase activity inhibitor derived from alpinia speciosa
Soliman Preparation of a regioselective quercetin-3-palmitate and its using for boosting cooking oil stability
Oboh et al. The Effect of Syrup Prepared from Elaeis guineensis jacq.(African Oil Palm) Sap and Honey on the Oxidation of Cooked Ground Beef during Short Term Storage
KR102154139B1 (en) Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract
KR100511222B1 (en) Cosmetic products containing the Dong-A extracts for inhibiting acne and a method for preparing thereof
KR20050101217A (en) Compound, process for producing the same and use thereof
KR20210066212A (en) Composition for preventing skin anti-aging comprising fermented black rice extract and fermented peanut sprout extract

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040908

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20040908

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040910

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060320

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060328

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060724